206 related articles for article (PubMed ID: 37148296)
81. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
Löck S; Linge A; Seidlitz A; Bandurska-Luque A; Nowak A; Gudziol V; Buchholz F; Aust DE; Baretton GB; Zöphel K; Steinbach J; Kotzerke J; Overgaard J; Zips D; Krause M; Baumann M; Troost EGC
Radiother Oncol; 2019 Jun; 135():43-50. PubMed ID: 31015169
[TBL] [Abstract][Full Text] [Related]
82. Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner.
Habrich J; Boeke S; Fritz V; Koerner E; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
Radiother Oncol; 2024 Feb; 191():110046. PubMed ID: 38070687
[TBL] [Abstract][Full Text] [Related]
83. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Covello M; Cavaliere C; Aiello M; Cianelli MS; Mesolella M; Iorio B; Rossi A; Nicolai E
Eur J Radiol; 2015 Jul; 84(7):1269-76. PubMed ID: 25958189
[TBL] [Abstract][Full Text] [Related]
84. Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study.
Subesinghe M; Scarsbrook AF; Sourbron S; Wilson DJ; McDermott G; Speight R; Roberts N; Carey B; Forrester R; Gopal SV; Sykes JR; Prestwich RJ
BMC Cancer; 2015 Mar; 15():137. PubMed ID: 25885109
[TBL] [Abstract][Full Text] [Related]
85. Multi-parametric PET/MRI for enhanced tumor characterization of patients with cervical cancer.
Ahangari S; Littrup Andersen F; Liv Hansen N; Jakobi Nøttrup T; Berthelsen AK; Folsted Kallehauge J; Richter Vogelius I; Kjaer A; Espe Hansen A; Fischer BM
Eur J Hybrid Imaging; 2022 Apr; 6(1):7. PubMed ID: 35378619
[TBL] [Abstract][Full Text] [Related]
86. Evaluation of non-Gaussian model-based diffusion-weighted imaging in oral squamous cell carcinoma: comparison with tumour functional information derived from positron-emission tomography.
Shima T; Fujima N; Yamano S; Kudo K; Hirata K; Minowa K
Clin Radiol; 2020 May; 75(5):397.e15-397.e21. PubMed ID: 31987487
[TBL] [Abstract][Full Text] [Related]
87. Hypoxia dose painting by numbers: a planning study.
Thorwarth D; Eschmann SM; Paulsen F; Alber M
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):291-300. PubMed ID: 17448882
[TBL] [Abstract][Full Text] [Related]
88. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.
Zips D; Zöphel K; Abolmaali N; Perrin R; Abramyuk A; Haase R; Appold S; Steinbach J; Kotzerke J; Baumann M
Radiother Oncol; 2012 Oct; 105(1):21-8. PubMed ID: 23022173
[TBL] [Abstract][Full Text] [Related]
89. Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Mammar H; Kerrou K; Nataf V; Pontvert D; Clemenceau S; Lot G; George B; Polivka M; Mokhtari K; Ferrand R; Feuvret L; Habrand JL; Pouysségur J; Mazure N; Talbot JN
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):681-7. PubMed ID: 22391104
[TBL] [Abstract][Full Text] [Related]
90. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
91. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
[TBL] [Abstract][Full Text] [Related]
92. Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer.
Wright P; Arnesen MR; Lønne PI; Suilamo S; Silvoniemi A; Dale E; Minn H; Malinen E
Acta Oncol; 2021 Nov; 60(11):1386-1391. PubMed ID: 34184605
[TBL] [Abstract][Full Text] [Related]
93. The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An
Mainta IC; Zilli T; Tille JC; De Perrot T; Vallée JP; Buchegger F; Garibotto V; Miralbell R
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1210-1218. PubMed ID: 29678527
[TBL] [Abstract][Full Text] [Related]
94. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.
Hicks RJ; Rischin D; Fisher R; Binns D; Scott AM; Peters LJ
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1384-91. PubMed ID: 16133382
[TBL] [Abstract][Full Text] [Related]
95. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
Quon H; Brizel DM
Semin Radiat Oncol; 2012 Jul; 22(3):220-32. PubMed ID: 22687947
[TBL] [Abstract][Full Text] [Related]
96. Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome.
Wiedenmann NE; Bucher S; Hentschel M; Mix M; Vach W; Bittner MI; Nestle U; Pfeiffer J; Weber WA; Grosu AL
Radiother Oncol; 2015 Oct; 117(1):113-7. PubMed ID: 26432067
[TBL] [Abstract][Full Text] [Related]
97. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
Varoquaux A; Rager O; Dulguerov P; Burkhardt K; Ailianou A; Becker M
Radiographics; 2015; 35(5):1502-27. PubMed ID: 26252192
[TBL] [Abstract][Full Text] [Related]
98. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
[TBL] [Abstract][Full Text] [Related]
99. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study.
; Mohamed ASR; Abusaif A; He R; Wahid KA; Salama V; Youssef S; McDonald BA; Naser M; Ding Y; Salzillo TC; AboBakr MA; Wang J; Lai SY; Fuller CD
Radiother Oncol; 2023 Jun; 183():109641. PubMed ID: 36990394
[TBL] [Abstract][Full Text] [Related]
100. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.
Morris ZS; Weichert JP; Saker J; Armstrong EA; Besemer A; Bednarz B; Kimple RJ; Harari PM
Radiother Oncol; 2015 Sep; 116(3):504-9. PubMed ID: 26123834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
